№ lp_1_33309
File format: docx Character count: 7033 File size: 102 KB
PCSK9 inhibitors are used for patients with primary hypercholesterolaemia or mixed dyslipidaemia who are not responsive to statins or are statin-intolerant, with a focus on reducing cardiovascular risk.
Note: Year
Topic: Lipid disorders, Cardiovascular Risk
Document Type: Medical guideline
Target Audience: Medical professionals, healthcare providers
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.